Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Nycomed GmbH
Abbott and Bigfoot Biomedical have worked as partners for more than half a decade but will now continue as one. Analysts are questioning whether the merger will simply be a tuck-in for Abbott, or enable it to release an insulin pump of their own.
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb looks back at ADA 2023 highlights and her interviews with diabetes company execs. Reed Miller discusses his Cardio Conversation with Volta Medical and Hannah Daniel discusses the FDA’s Clinical Decision Support Software final guidance.
Turnstone’s initial public offering comes just one week after Apogee and Sagimet launched US IPOs. Also, Westlake Village BioPartners raised $450m for its third venture capital fund and argenx grossed $1.27bn in a post-Phase III follow-on offering.
In this final Exec Chat in our series with leaders of major diabetes companies that presented at ADA’s Scientific Session 2023, Bigfoot Biomedical’s CMO James Malone and senior medical director Jeanne Jacoby discuss plans for the firm’s Unity diabetes management platform and its shift into the pharmacy channel.
- Medical Devices
- OTC, Consumer
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
- Bradley Pharmaceuticals, Guangdong Techpool Bio-Pharma Co., Ltd.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.